AMR Accelerator

AMR Stakeholder Profile

AMR Accelerator

Focus area/active in: Human Health

Company/Organisation type: Association | Cluster | Network

The aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or even prevent resistant bacterial infections in Europe and worldwide. The AMR Accelerator comprises 9 projects with focus on Tuberculosis, Gram-negative bacteria, and capability building. The scope of the AMR Accelerator is broad; under one structure, it addresses many of the scientific challenges of AMR, with the shared goal is to progress the development of new medicines to treat or prevent resistant bacterial infections.


Follow us:

AMR Accelerator Newsletter

Please sign up here for our bi-annual newsletter
"The AMR Accelerator shows how collaboration and solidarity allow researchers to contribute to the elimination of antibiotic-resistant tuberculosis and AMR"
Pierre Meulien
Executive Director, IHI

Get in touch!

Prof. Anders Karlén
COMBINE Project Coordinator

Please fill out the form below to get in touch with us.

Share this page:

Share on twitter
Share on linkedin